Cargando…
Luces y sombras de la Guía Europea esc-2021 de Prevención de la Enfermedad Cardiovascular en la Práctica Clínica
General practitioners see in their consultation a a significant number of patients at high vascular risk (VR). The European Guidelines for Cardiovascular Disease Prevention (2021) recommend a new risk classification and intervention strategies on on vascular risk factors (RF), with the aim of provid...
Autores principales: | , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Ministerio de Sanidad
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10541257/ https://www.ncbi.nlm.nih.gov/pubmed/37921403 |
_version_ | 1785113877669740544 |
---|---|
author | Martín-Rioboó, Enrique Brotons-Cuixart, Carlos Ruiz García, Antonio Villafañe Sanz, Fátima Frías Vargas, Manuel Moyá Amengual, Ana Divisón Garrote, Juan Antonio Seoane Vicente, María Cruz Banegas, José R. Pallarés Carratalá, Vicente |
author_facet | Martín-Rioboó, Enrique Brotons-Cuixart, Carlos Ruiz García, Antonio Villafañe Sanz, Fátima Frías Vargas, Manuel Moyá Amengual, Ana Divisón Garrote, Juan Antonio Seoane Vicente, María Cruz Banegas, José R. Pallarés Carratalá, Vicente |
author_sort | Martín-Rioboó, Enrique |
collection | PubMed |
description | General practitioners see in their consultation a a significant number of patients at high vascular risk (VR). The European Guidelines for Cardiovascular Disease Prevention (2021) recommend a new risk classification and intervention strategies on on vascular risk factors (RF), with the aim of providing a shared decision-making recommendations between professionals and patients. In this document we present a critical analysis of these guidelines, offering possible solutions that can be implemented in Primary Care. It should be noted that there are positive aspects (lights) such as that the SCORE2 (from forty to sixty-nine years) and SCORE2-OP models (from seventy to eighty-nine years) are based on more current cohorts and measure cardiovascular risk in a more accurately manner. In addition, it is proposed to differentiate different risk thresholds according to age-groups. For sake of practicality, cardiovascular risk can be estimated using different websites with the new computer models. However, among the negative aspects (shadows), it seems to be add complexity implementing nine subgroups of subjects according to their age or level of risk, with a defined thresholds that could cause a substantial increase in the potential number of subjects susceptible to treatment without a clear evidence that supports it. In addition, two-step RF interventions could delay achievement of therapeutic goals, especially in very high-risk patients, diabetics, or patients with cardiovascular disease. Given these limitations, in this document we propose practical recommendations in order to simplify and facilitate the implementation of the guideline in primary care. |
format | Online Article Text |
id | pubmed-10541257 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2023 |
publisher | Ministerio de Sanidad |
record_format | MEDLINE/PubMed |
spelling | pubmed-105412572023-10-06 Luces y sombras de la Guía Europea esc-2021 de Prevención de la Enfermedad Cardiovascular en la Práctica Clínica Martín-Rioboó, Enrique Brotons-Cuixart, Carlos Ruiz García, Antonio Villafañe Sanz, Fátima Frías Vargas, Manuel Moyá Amengual, Ana Divisón Garrote, Juan Antonio Seoane Vicente, María Cruz Banegas, José R. Pallarés Carratalá, Vicente Rev Esp Salud Publica Colaboración Especial General practitioners see in their consultation a a significant number of patients at high vascular risk (VR). The European Guidelines for Cardiovascular Disease Prevention (2021) recommend a new risk classification and intervention strategies on on vascular risk factors (RF), with the aim of providing a shared decision-making recommendations between professionals and patients. In this document we present a critical analysis of these guidelines, offering possible solutions that can be implemented in Primary Care. It should be noted that there are positive aspects (lights) such as that the SCORE2 (from forty to sixty-nine years) and SCORE2-OP models (from seventy to eighty-nine years) are based on more current cohorts and measure cardiovascular risk in a more accurately manner. In addition, it is proposed to differentiate different risk thresholds according to age-groups. For sake of practicality, cardiovascular risk can be estimated using different websites with the new computer models. However, among the negative aspects (shadows), it seems to be add complexity implementing nine subgroups of subjects according to their age or level of risk, with a defined thresholds that could cause a substantial increase in the potential number of subjects susceptible to treatment without a clear evidence that supports it. In addition, two-step RF interventions could delay achievement of therapeutic goals, especially in very high-risk patients, diabetics, or patients with cardiovascular disease. Given these limitations, in this document we propose practical recommendations in order to simplify and facilitate the implementation of the guideline in primary care. Ministerio de Sanidad 2023-08-16 /pmc/articles/PMC10541257/ /pubmed/37921403 Text en https://creativecommons.org/licenses/by-nc-nd/3.0/Este es un artículo publicado en acceso abierto bajo una licencia Creative Commons |
spellingShingle | Colaboración Especial Martín-Rioboó, Enrique Brotons-Cuixart, Carlos Ruiz García, Antonio Villafañe Sanz, Fátima Frías Vargas, Manuel Moyá Amengual, Ana Divisón Garrote, Juan Antonio Seoane Vicente, María Cruz Banegas, José R. Pallarés Carratalá, Vicente Luces y sombras de la Guía Europea esc-2021 de Prevención de la Enfermedad Cardiovascular en la Práctica Clínica |
title | Luces y sombras de la Guía Europea esc-2021 de Prevención de la Enfermedad Cardiovascular en la Práctica Clínica |
title_full | Luces y sombras de la Guía Europea esc-2021 de Prevención de la Enfermedad Cardiovascular en la Práctica Clínica |
title_fullStr | Luces y sombras de la Guía Europea esc-2021 de Prevención de la Enfermedad Cardiovascular en la Práctica Clínica |
title_full_unstemmed | Luces y sombras de la Guía Europea esc-2021 de Prevención de la Enfermedad Cardiovascular en la Práctica Clínica |
title_short | Luces y sombras de la Guía Europea esc-2021 de Prevención de la Enfermedad Cardiovascular en la Práctica Clínica |
title_sort | luces y sombras de la guía europea esc-2021 de prevención de la enfermedad cardiovascular en la práctica clínica |
topic | Colaboración Especial |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10541257/ https://www.ncbi.nlm.nih.gov/pubmed/37921403 |
work_keys_str_mv | AT martinriobooenrique lucesysombrasdelaguiaeuropeaesc2021deprevenciondelaenfermedadcardiovascularenlapracticaclinica AT brotonscuixartcarlos lucesysombrasdelaguiaeuropeaesc2021deprevenciondelaenfermedadcardiovascularenlapracticaclinica AT ruizgarciaantonio lucesysombrasdelaguiaeuropeaesc2021deprevenciondelaenfermedadcardiovascularenlapracticaclinica AT villafanesanzfatima lucesysombrasdelaguiaeuropeaesc2021deprevenciondelaenfermedadcardiovascularenlapracticaclinica AT friasvargasmanuel lucesysombrasdelaguiaeuropeaesc2021deprevenciondelaenfermedadcardiovascularenlapracticaclinica AT moyaamengualana lucesysombrasdelaguiaeuropeaesc2021deprevenciondelaenfermedadcardiovascularenlapracticaclinica AT divisongarrotejuanantonio lucesysombrasdelaguiaeuropeaesc2021deprevenciondelaenfermedadcardiovascularenlapracticaclinica AT seoanevicentemariacruz lucesysombrasdelaguiaeuropeaesc2021deprevenciondelaenfermedadcardiovascularenlapracticaclinica AT banegasjoser lucesysombrasdelaguiaeuropeaesc2021deprevenciondelaenfermedadcardiovascularenlapracticaclinica AT pallarescarratalavicente lucesysombrasdelaguiaeuropeaesc2021deprevenciondelaenfermedadcardiovascularenlapracticaclinica |